page full analyst note feb
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim jan
price data feb
rate updat feb
currenc amount express
valuat growth profit
methodolog valu compani
spun hewlett-packard agil evolv
seri transact lead healthcar firm market
share leader mani core product categori agil
global measur giant use technolog expertis
global reach serv broad base scienc engin
custom spin electron segment novemb
name agil focus
sole life scienc diagnost chemic analysi
agil leverag competit edg electron
measur market emerg major player life
scienc market spin-off electron unit allow
agil focu chemic analysi life scienc market
present better growth opportun enhanc
compani moat higher barrier entri switch
field despit near-term challeng
constrain academ research budget weak oil ga
market agil continu benefit higher growth
among biopharma research appli industri market
also think manag priorit build diagnost
busi acquisit dako compani
smaller market share less expertis potenti
faster-grow larger clinic market opportun
agil possess larg global market distribut
infrastructur leav firm well-equip handl
competit enhanc profit oper margin
method improv sinc see gain ahead
recent effici cost-sav effort -- streamlin
suppli chain exit unprofit nmr busi enhanc
procur consolid facil outsourc noncrit
task -- boost profit make agil less suscept
swing demand compani decad ago agil
direct presenc emerg market also help solidifi custom
relationship help enhanc demand
compani product faster-growth region
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
origin spun hewlett-packard agil evolv
broad base custom within three oper segment life scienc
appli equip sale cross lab includ
consum servic diagnost genom
unit state europ account revenu
respect china japan account major remain
sale agil headquart california
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
perform show continu benefit
market share gain margin expans previous
felt manag year-end outlook conserv
given compani recent perform updat
estim top previou view manag
anticip billion revenu
adjust ep midpoint year like
increas fair valu estim slightli remaind
year face difficult growth comparison last
year addit quarter perform benefit
pull-forward demand equip lunar new
year celebr china lead slower
growth second quarter currenc remain signific
tailwind ad growth top
compani organ growth quarter
manag estim top-lin
ep currenc benefit year adjust oper margin
expans basi point slightli ahead
margin expans effort continu pay
seem gain custom traction benefit
growth margin come quarter addit
advanc buy china europ also wit
increas demand especi segment like academia
turnaround chemic energi custom
segment last year continu quarter growth
growth pharma custom categori mostli
match expect segment order backlog
improv end perform stabl across
small molecul biopharma custom despit
concern pharma consolid competit issu
gener industri dont forese major
disrupt agil area
valuat growth profit jan
rais fair valu estim agil per
share account time valu money sinc
last updat slightli rais sale growth
forecast follow firm recent out-performance
slightli increas revenu forecast lower
forward price/adjust earn multipl approxim
next five year think adjust earn
grow close time frame thank
leverag effici effort share
annual growth result mid-single-digit
growth agil life scienc appli divis
biopharma food industri growth along recent
recoveri energi market custom base help
off-set weaker growth academ govern
segment expect modest recoveri agil sale
improv market condit continu slowli eas
custom budget constraint especi academ
research market macroeconom issu europ
japan remain near-term concern agil growth
appli diagnost market remain rel
strong market share gain new product launch
rise contribut emerg market also help
expect profit continu improv year
ahead product mix oper leverag increas
global demand cost-sav initi synergi
acquisit agil also exit less profit
busi nmr mri busi acquir
varian deal compani improv economi
scale life scienc diagnost market also
eventu drive consider portion consolid
margin expans assum modest margin expans
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
strong price cost control effort lead adjust
oper margin near
bull-cas fair valu estim per share
bear case competit price pressur across
busi segment hinder growth profit
project approxim revenu growth annual
next sever year adjust oper margin
remain near due strong compet platform
peer slowdown emerg market continu
budgetari constraint auster measur price
pressur bear-cas fair valu estim per share
return capit averag high teen
high custom switch cost moder barrier
entri competitor primari ingredi agil
narrow econom moat opinion extens
portfolio intang asset far-reach global
infrastructur also critic support compani
agil benefit much peer
recur consum sale compani nonetheless
enjoy long product life cycl typic five year
high custom retent rate persist decad
agil cater highli skill engin scientist
face steep learn curv sizabl up-front invest
util special highli sensit equip
market scientist often remain loyal supplier
ensur sampl protect standard
valid requir scientif research regulatori
reinforc high switch cost brand
instrument reagent market tend
incorpor high level technolog complex
also keep barrier entri somewhat high opinion
life scienc diagnost segment lead
adjust oper margin near model
assumpt culmin five-year averag return
capit high teen estim agil cost
capit approxim
award agil medium uncertainti rate thank
rel high barrier entri moder switch
cost mostli stabl product evolut
chromatographi diagnost instrument market
bull-cas scenario assum european
budgetari pressur quickli resolv agil
custom resum spend normal level also
forecast stronger growth within asian emerg
market assum firm abl capit strong
demand trend key end segment exampl increas
popul mobil grow global energi need food
safeti help boost compani market share
project robust revenu growth life scienc segment
scenario project compound annual growth near
overal revenu exceed billion
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
market
addit challeng manufactur reliabl
complex instrument think necessari servic
compon
consult repair present hurdl new entrant
establish reput brand supplement exist
offer keep pace technolog advanc
agil consist alloc larg portion resourc
toward research develop sale
instrument autom
matter addit agil proven histori
adapt new
industri accret
acquisit
acquisit dako exampl brought signific
capabl scale within anatom patholog
market boost agil percentag recur
think agil moat support stabl posit
firm comfort oligopoli includ consist
competitor shimadzu thermo fisher
agil roughli market
share life scienc diagnost chemic analysi
divis estim howev within larg market
chemic energi
environment food segment thank larg part
compani domin within ga chromatographi
market dako acquisit agil roughli
market share anatom patholog market
tissue-bas cancer diagnost make major player
roch
agil stabl moat trend view compet
rel stabl market think risk disrupt
technolog low particularli matur chemic
analysi market agil on-going transit
clinic diagnost appli market pose new
concentr
potenti lower brand loyalti pit power foe
nimbl entrant disrupt technolog like genom
sequenc agil may difficulti translat
histor advantag clinic market regardless
think agil familiar competit dynam
within clinic diagnost market includ workflow
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oagil well-establish leader mani core
familiar agil
instrument servic make market share
gain new entrant difficult
oa signific portion agil busi
depend research compos larg academ
govern institut like face
continu budget constraint near term
oagil spin-off electron measur
segment free resourc focu build
compani life scienc diagnost
chemic analysi oper -- higher-growth
differenti industri
oth acquisit dako enhanc agil
access higher-growth larger clinic
diagnost market boost compani
oagil must continu innov stay
forefront technolog advanc particularli
compet even larger compani
oacquisit divest central
compon agil strategi place high
demand manag abil execut market
expans integr goal
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
agil retain strong financi posit view
end fiscal year octob compani
billion cash balanc exceed nearli billion total debt
compani gross debt/ebitda remain around
comfort ebitda interest expens coverag ratio
greater manag continu return
signific capit sharehold dividend
share repurchas although larg acquisit
common agil manag like continu
util portion free cash flow smaller deal
award agil medium uncertainti rate thank
rel high barrier entri moder switch
cost mostli stabl product evolut
chromatographi diagnost instrument market agil
larg depend capit equip sale
volatil subject macroeconom condit
compon agil suscept capital-spend
cycl roic could risk event prolong
downturn although focus reduc relianc
agil still gener level high-margin
consum servic sale wide- narrow-moat
rival includ thermo fisher
agil also oper competit environ
establish competitor new entrant introduc better
product develop stronger relationship custom
compani may lose market share well abil
extract price increas moreov compani compet
mani smaller more-focus rival invest
signific resourc segment requir
maintain technolog edg exampl agil
current particip equip side
genom sequenc market could pose risk
road technolog potenti displac
current research clinic method regardless agil
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
larg chromatographi mass spectrometri busi
seem larg immun disrupt technolog
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
fidel manag research compani
share
fund
share
fund
assign compani standard mark stewardship
term capit alloc think manag wise
use acquisit divestitur keysight
technolog spin-off improv asset product
agil may aggress consolid
peer thermo fisher think
manag disciplin help uphold consist
attract return capit also believ manag
display nice track record use deal build
capabl within new market acquisit
dako exampl come steep price tag think
manag make appropri stride improv
busi asset util purchas step
stone enter higher-growth clinic diagnost arena
spin-off keysight mike mcmullen previous
presid chemic analysi segment sinc
replac william sullivan ceo agil earli
mcmullen long histori compani origin
hewlett-packard date back william sullivan
agil veteran compani sinc
spin-off hewlett-packard previous
agil ceo sinc full retir octob
sullivan remain advisori role
mcmullen transit leadership didier hirsch also
hewlett-packard veteran like mcmullen remain cfo
agil mcmullen also possess one seat agil
board director koh boon hwee -- board
member sinc jame cullen chairman
board cullen chairman sinc
remain member board although board
switch measur execut compens
oper margin adjust ep instead return
capit think manag compens reason
option issuanc excess
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
agil end fiscal year strong note despit pharma
sale declin share look overvalu
organ revenu growth oper margin
expans roughli basi point sale slightli
ahead expect think manag outlook
includ earn per share
estim also
conserv given recent momentum busi
regardless dont anticip materi shift fair
valu estim stock still look overvalu view
trade nearli time high end manag
earn outlook nov close current market
valuat seem difficult justifi given expect
limit improv long-term growth margin
expans current level even though believ
agil narrow moat remain solid shape
rebound academ energi market perform led
strong quarter agil help off-set declin
pharma sale quarter add tailwind
declin due tough year-over-year comparison sale
climb period last year combin
delay order europ lumpi nucleic acid batch
revenu still think trajectori divis remain
strong even though agil growth moder
previou perform becom difficult outpac
particularli recent gain liquid chromatographi
suggest recoveri pharma sale first half next
still think market remain sluggish despit
quarter impress result suggest agil
gain market share food environment
diagnost segment sale growth
respect fell line previou quarter mostli
match forecast
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end octob
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end octob
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
